Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS1M
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -2.8 %
2W 0.4 %
1M 6.1 %
3M -3.1 %
6M 8.7 %
9M -6.5 %
1Y -81.9 %
Alpha
-97.3%
Beta
0.69
sharpe-R
-0.94
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:01:06
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -86.36%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 16.74% -9.54%
HROW Harrow Health, Inc. Sell -6.8% 5.79%
The percentage of cash held in the portfolio is: 90.06%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 16.74% -9.54%
HROW Harrow Health, Inc. Sell -6.8% 5.79%
The percentage of cash held in the portfolio is: 90.06%
New Assets Added
None
Assets Removed
Asset Action Perf %
HAE Buy All 15.19%
MD Sell All 0.36%
ORGO Sell All 11.11%
Assets Rebalanced
None
2025-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 11.89% 3.36%
ORGO Organogenesis Holdings Inc. Buy 12.16% 10.51%
RGNX REGENXBIO Inc. Buy 16.78% -9.29%
HAE Haemonetics Corporation Sell -6.13% 15.29%
HROW Harrow Health, Inc. Sell -7.13% 1.18%
The percentage of cash held in the portfolio is: 72.43%
New Assets Added
None
Assets Removed
Asset Action Perf %
ACRS Sell All -12%
Assets Rebalanced
None
2025-02-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACRS Aclaris Therapeutics, Inc. Buy 10.18% -13.2%
MD Pediatrix Medical Group, Inc. Buy 11.72% 1.79%
ORGO Organogenesis Holdings Inc. Buy 12.11% 9.91%
RGNX REGENXBIO Inc. Buy 16.53% -10.78%
HAE Haemonetics Corporation Sell -6.04% 16.62%
HROW Harrow Health, Inc. Sell -6.7% 7.28%
The percentage of cash held in the portfolio is: 62.2%
New Assets Added
None
Assets Removed
Asset Action Perf %
AXGN Sell All -2.52%
Assets Rebalanced
None
2025-02-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 11.01% -2.9%
ACRS Aclaris Therapeutics, Inc. Buy 11.03% -4.4%
MD Pediatrix Medical Group, Inc. Buy 11.31% -0.14%
ORGO Organogenesis Holdings Inc. Buy 11.62% 7.21%
RGNX REGENXBIO Inc. Buy 17.82% -2.23%
HAE Haemonetics Corporation Sell -5.87% 17.53%
HROW Harrow Health, Inc. Sell -7.05% 0.9%
The percentage of cash held in the portfolio is: 50.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
INSM Sell All 13.33%
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 11.01% -1.59%
INSM Insmed Incorporated Buy 11.65% 15.99%
ACRS Aclaris Therapeutics, Inc. Buy 11.34% -0.4%
MD Pediatrix Medical Group, Inc. Buy 10.88% -2.64%
ORGO Organogenesis Holdings Inc. Buy 11.11% 3.9%
RGNX REGENXBIO Inc. Buy 18.3% 1.73%
HAE Haemonetics Corporation Sell -5.67% 19.3%
HROW Harrow Health, Inc. Sell -6.74% 3.96%
The percentage of cash held in the portfolio is: 38.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORMP Buy All 8.82%
AORT Sell All 1.06%
MDXG Sell All -5.78%
Assets Rebalanced
None
2025-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.13% 3.44%
AXGN AxoGen, Inc. Buy 11.13% 0.44%
INSM Insmed Incorporated Buy 11.66% 17.19%
ACRS Aclaris Therapeutics, Inc. Buy 10.96% -2.8%
MD Pediatrix Medical Group, Inc. Buy 10.84% -2.14%
MDXG MiMedx Group, Inc. Buy 10.95% -3.63%
ORGO Organogenesis Holdings Inc. Buy 11.29% 6.61%
RGNX REGENXBIO Inc. Buy 18.61% 4.46%
ORMP Oramed Pharmaceuticals Inc. Sell -4.92% 7.14%
HAE Haemonetics Corporation Sell -5.96% 14.33%
HROW Harrow Health, Inc. Sell -6.68% 3.87%
The percentage of cash held in the portfolio is: 20.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Buy All 20%
NUTX Sell All 54.16%
Assets Rebalanced
None
2025-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.37% 2.51%
AXGN AxoGen, Inc. Buy 11.32% -0.93%
INSM Insmed Incorporated Buy 12.05% 17.53%
ACRS Aclaris Therapeutics, Inc. Buy 11.67% 0.4%
MD Pediatrix Medical Group, Inc. Buy 11.34% -0.64%
MDXG MiMedx Group, Inc. Buy 11.36% -3.06%
ORGO Organogenesis Holdings Inc. Buy 11.41% 4.5%
NUTX Nutex Health Inc. Buy 13.84% 26.47%
RGNX REGENXBIO Inc. Buy 19.19% 4.46%
FATE Fate Therapeutics, Inc. Sell -4.1% 25.14%
ORMP Oramed Pharmaceuticals Inc. Sell -5.02% 7.98%
HAE Haemonetics Corporation Sell -6.73% 6.27%
HROW Harrow Health, Inc. Sell -6.84% 4.52%
The percentage of cash held in the portfolio is: 9.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDRX Buy All 47.11%
Assets Rebalanced
None
2025-02-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.48% 1.19%
AXGN AxoGen, Inc. Buy 11.47% -1.81%
INSM Insmed Incorporated Buy 11.85% 12.98%
ACRS Aclaris Therapeutics, Inc. Buy 11.42% -4%
MD Pediatrix Medical Group, Inc. Buy 11.61% -0.57%
MDXG MiMedx Group, Inc. Buy 11.6% -3.17%
ORGO Organogenesis Holdings Inc. Buy 11.44% 2.4%
NUTX Nutex Health Inc. Buy 14.25% 27.3%
RGNX REGENXBIO Inc. Buy 18.2% -3.1%
FATE Fate Therapeutics, Inc. Sell -4.07% 27.43%
ORMP Oramed Pharmaceuticals Inc. Sell -5.07% 9.24%
HAE Haemonetics Corporation Sell -6.6% 10.04%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.54% 44.44%
HROW Harrow Health, Inc. Sell -6.77% 7.62%
The percentage of cash held in the portfolio is: 12.72%
New Assets Added
None
Assets Removed
Asset Action Perf %
SIGA Sell All -9.55%
Assets Rebalanced
None
2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.49% 2.41%
AXGN AxoGen, Inc. Buy 11.53% -0.22%
INSM Insmed Incorporated Buy 11.52% 11.1%
ACRS Aclaris Therapeutics, Inc. Buy 11.67% -0.8%
MD Pediatrix Medical Group, Inc. Buy 11.53% -0.14%
MDXG MiMedx Group, Inc. Buy 11.69% -1.36%
ORGO Organogenesis Holdings Inc. Buy 12.21% 10.51%
NUTX Nutex Health Inc. Buy 13.7% 23.71%
SIGA SIGA Technologies, Inc. Buy 10.95% -6.42%
RGNX REGENXBIO Inc. Buy 18.58% 0%
FATE Fate Therapeutics, Inc. Sell -4.12% 25.71%
ORMP Oramed Pharmaceuticals Inc. Sell -5.19% 5.88%
HAE Haemonetics Corporation Sell -6.82% 6.09%
MDRX Allscripts Healthcare Solutions, Inc. Sell -3.83% 39.33%
HROW Harrow Health, Inc. Sell -6.89% 4.86%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGNX
Assets Removed
Asset Action Perf %
TGTX Sell All -0.69%
Assets Rebalanced
None
2025-01-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.73% 1.36%
AXGN AxoGen, Inc. Buy 11.7% -1.75%
INSM Insmed Incorporated Buy 12.04% 12.62%
ACRS Aclaris Therapeutics, Inc. Buy 11.88% -2%
MD Pediatrix Medical Group, Inc. Buy 12.48% 4.86%
MDXG MiMedx Group, Inc. Buy 12.06% -1.25%
ORGO Organogenesis Holdings Inc. Buy 12.79% 12.31%
NUTX Nutex Health Inc. Buy 12% 5.09%
SIGA SIGA Technologies, Inc. Buy 11.97% -0.78%
TGTX TG Therapeutics, Inc. Buy 19.35% 0%
FATE Fate Therapeutics, Inc. Sell -4.48% 21.71%
ORMP Oramed Pharmaceuticals Inc. Sell -5.36% 5.88%
HAE Haemonetics Corporation Sell -7.26% 3.05%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.44% 16.33%
HROW Harrow Health, Inc. Sell -7.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HROW
  • TGTX
Assets Removed
Asset Action Perf %
ESPR Sell All -14.96%
Assets Rebalanced
None
2025-01-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.6% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 12.37% -10.26%
AXGN AxoGen, Inc. Buy 11.7% -0.6%
INSM Insmed Incorporated Buy 12.04% 13.85%
ACRS Aclaris Therapeutics, Inc. Buy 12.04% 0.4%
MD Pediatrix Medical Group, Inc. Buy 12.04% 2.29%
MDXG MiMedx Group, Inc. Buy 12.04% -0.34%
ORGO Organogenesis Holdings Inc. Buy 12.04% 6.91%
NUTX Nutex Health Inc. Buy 12.47% 10.49%
SIGA SIGA Technologies, Inc. Buy 12.04% 0.94%
FATE Fate Therapeutics, Inc. Sell -4.3% 24%
ORMP Oramed Pharmaceuticals Inc. Sell -5.37% 4.62%
HAE Haemonetics Corporation Sell -7.13% 3.69%
MDRX Allscripts Healthcare Solutions, Inc. Sell -5.57% 13.33%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
TGTX Buy All -11.64%
Assets Rebalanced
Asset Action Weight
AXGN Sell -1.98%
ACRS Sell -1.81%
INSM Sell -3.64%
ORGO Sell -23.86%
NUTX Buy 1.71%
SIGA Buy 4.12%
MD Buy 9.28%
MDXG Buy 9.35%
2025-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 11.71% 1.82%
ESPR Esperion Therapeutics, Inc. Buy 13.02% -5.98%
AXGN AxoGen, Inc. Buy 14.33% 3.51%
INSM Insmed Incorporated Buy 15.75% 13.81%
ACRS Aclaris Therapeutics, Inc. Buy 14.42% 4%
MD Pediatrix Medical Group, Inc. Buy 2.72% 0.5%
MDXG MiMedx Group, Inc. Buy 2.76% 1.93%
ORGO Organogenesis Holdings Inc. Buy 35.47% 5.11%
NUTX Nutex Health Inc. Buy 9.3% -1.01%
SIGA SIGA Technologies, Inc. Buy 7.88% 0%
TGTX TG Therapeutics, Inc. Sell -5.99% -4.07%
FATE Fate Therapeutics, Inc. Sell -4.35% 23.43%
ORMP Oramed Pharmaceuticals Inc. Sell -5.49% 2.94%
HAE Haemonetics Corporation Sell -7.42% 0.24%
MDRX Allscripts Healthcare Solutions, Inc. Sell -6.12% 5.33%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SIGA
Assets Removed
Asset Action Perf %
BLUE Sell All -20.97%
Assets Rebalanced
None
2025-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.2% -17.94%
AORT Artivion, Inc. Buy 12.03% 4.5%
ESPR Esperion Therapeutics, Inc. Buy 12.74% -8.12%
AXGN AxoGen, Inc. Buy 14.41% 3.95%
INSM Insmed Incorporated Buy 15.43% 11.34%
ACRS Aclaris Therapeutics, Inc. Buy 14.44% 4%
MD Pediatrix Medical Group, Inc. Buy 2.71% 0%
MDXG MiMedx Group, Inc. Buy 2.81% 3.63%
ORGO Organogenesis Holdings Inc. Buy 35.82% 6.01%
NUTX Nutex Health Inc. Buy 9.41% 0%
TGTX TG Therapeutics, Inc. Sell -6.15% -6.64%
FATE Fate Therapeutics, Inc. Sell -4.29% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.47% 3.36%
HAE Haemonetics Corporation Sell -7.62% -2.33%
MDRX Allscripts Healthcare Solutions, Inc. Sell -6.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
  • NUTX
Assets Removed
Asset Action Perf %
APLS Buy All -9.8%
TNDM Sell All -5.5%
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.49% -16.73%
TNDM Tandem Diabetes Care, Inc. Buy 10.24% 0.47%
AORT Artivion, Inc. Buy 12.14% 3.34%
ESPR Esperion Therapeutics, Inc. Buy 13.67% -3.42%
AXGN AxoGen, Inc. Buy 14.28% 0.99%
INSM Insmed Incorporated Buy 14.92% 5.54%
ACRS Aclaris Therapeutics, Inc. Buy 14.22% 0.4%
MD Pediatrix Medical Group, Inc. Buy 2.72% -1.64%
MDXG MiMedx Group, Inc. Buy 2.85% 2.95%
ORGO Organogenesis Holdings Inc. Buy 34.48% 0%
TGTX TG Therapeutics, Inc. Sell -6.12% -4.07%
FATE Fate Therapeutics, Inc. Sell -4.15% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.63% 2.52%
APLS Apellis Pharmaceuticals, Inc. Sell -6.51% -8.35%
HAE Haemonetics Corporation Sell -7.6% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HAE
  • ORGO
Assets Removed
Asset Action Perf %
NUTX Buy All -22.6%
MDRX Sell All -6.56%
Assets Rebalanced
None
2025-01-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.86% -16.43%
TNDM Tandem Diabetes Care, Inc. Buy 10.21% -3.76%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.85% -4.51%
AORT Artivion, Inc. Buy 12.15% -0.56%
ESPR Esperion Therapeutics, Inc. Buy 13.91% -5.56%
AXGN AxoGen, Inc. Buy 15.1% 2.63%
INSM Insmed Incorporated Buy 14.99% 1.84%
ACRS Aclaris Therapeutics, Inc. Buy 14.8% 0.4%
MD Pediatrix Medical Group, Inc. Buy 2.88% 0%
MDXG MiMedx Group, Inc. Buy 2.88% 0%
TGTX TG Therapeutics, Inc. Sell -6.59% -7.79%
FATE Fate Therapeutics, Inc. Sell -4.56% 24.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.91% 1.68%
NUTX Nutex Health Inc. Sell 15.05% -5.86%
APLS Apellis Pharmaceuticals, Inc. Sell -6.61% -5.79%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • MDXG
Assets Removed
Asset Action Perf %
ARDX Sell All 0.19%
Assets Rebalanced
None
2025-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 8.61% -19.25%
TNDM Tandem Diabetes Care, Inc. Buy 10.21% -4.19%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.66% -6.67%
AORT Artivion, Inc. Buy 12.06% -1.82%
ARDX Ardelyx, Inc. Buy 12.93% 5.24%
ESPR Esperion Therapeutics, Inc. Buy 14.17% -4.27%
AXGN AxoGen, Inc. Buy 14.78% -0.05%
INSM Insmed Incorporated Buy 14.65% -0.93%
ACRS Aclaris Therapeutics, Inc. Buy 14.81% 0%
NUTX Nutex Health Inc. Sell 14.81% -3.63%
TGTX TG Therapeutics, Inc. Sell -6.53% -6.21%
FATE Fate Therapeutics, Inc. Sell -4.34% 28.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0.84%
APLS Apellis Pharmaceuticals, Inc. Sell -6.34% -0.91%
The percentage of cash held in the portfolio is: -4.51%
New Assets Added
  • NUTX
  • ACRS
Assets Removed
None
Assets Rebalanced
None
2025-01-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.1% -3.07%
BLUE bluebird bio, Inc. Buy 8.92% -14.42%
MDRX Allscripts Healthcare Solutions, Inc. Buy 10.88% -2.56%
AORT Artivion, Inc. Buy 11.65% -2.94%
ARDX Ardelyx, Inc. Buy 13.22% 10.11%
ESPR Esperion Therapeutics, Inc. Buy 14.09% -2.56%
AXGN AxoGen, Inc. Buy 14.46% 0%
INSM Insmed Incorporated Buy 14.46% 0%
TGTX TG Therapeutics, Inc. Sell -5.94% 1.18%
FATE Fate Therapeutics, Inc. Sell -4.37% 26.29%
ORMP Oramed Pharmaceuticals Inc. Sell -5.86% 0.84%
NUTX Nutex Health Inc. Sell -6.12% 0.39%
APLS Apellis Pharmaceuticals, Inc. Sell -6.4% -4.19%
The percentage of cash held in the portfolio is: 30.91%
New Assets Added
  • AXGN
  • INSM
Assets Removed
None
Assets Rebalanced
None
2025-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.25% -3.63%
BLUE bluebird bio, Inc. Buy 9.07% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.11% -2.46%
AORT Artivion, Inc. Buy 12.11% -1.16%
ARDX Ardelyx, Inc. Buy 11.64% -5.06%
ESPR Esperion Therapeutics, Inc. Buy 14.76% 0%
TGTX TG Therapeutics, Inc. Sell -6.33% -3.14%
FATE Fate Therapeutics, Inc. Sell -5.09% 16%
ORMP Oramed Pharmaceuticals Inc. Sell -6.05% -0.42%
NUTX Nutex Health Inc. Sell -6.27% 0%
APLS Apellis Pharmaceuticals, Inc. Sell -6.27% 0%
The percentage of cash held in the portfolio is: 61.06%
New Assets Added
  • NUTX
  • APLS
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2025-01-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.61% 0.36%
BLUE bluebird bio, Inc. Buy 9.02% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.05% -2.46%
AORT Artivion, Inc. Buy 12.19% 0%
ARDX Ardelyx, Inc. Buy 12.19% 0%
TGTX TG Therapeutics, Inc. Sell -6.27% -2.75%
FATE Fate Therapeutics, Inc. Sell -5.75% 4.57%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0%
The percentage of cash held in the portfolio is: 62.95%
New Assets Added
  • ORMP
  • AORT
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2025-01-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.42% -0.82%
BLUE bluebird bio, Inc. Buy 9.55% -9.07%
MDRX Allscripts Healthcare Solutions, Inc. Buy 11.26% 0%
TGTX TG Therapeutics, Inc. Sell -6.06% 0%
FATE Fate Therapeutics, Inc. Sell -5.98% 0%
The percentage of cash held in the portfolio is: 80.81%
New Assets Added
  • FATE
  • MDRX
Assets Removed
None
Assets Rebalanced
None
2025-01-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 10.4% 0%
BLUE bluebird bio, Inc. Buy 10.4% 0%
TGTX TG Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 85.2%
New Assets Added
  • TGTX
  • TNDM
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2025-01-06 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PCRX Sell All -3.61%
Assets Rebalanced
None
2024-12-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 12.19% 3.77%
The percentage of cash held in the portfolio is: 87.81%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All 1%
MGNX Sell All -4.12%
Assets Rebalanced
None
2024-12-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.04% 1.56%
MGNX MacroGenics, Inc. Buy 11.09% -6.47%
PCRX Pacira BioSciences, Inc. Buy 12.09% 2.51%
The percentage of cash held in the portfolio is: 64.78%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Buy All -49.27%
Assets Rebalanced
None
2024-12-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 11.92% 4.2%
MGNX MacroGenics, Inc. Buy 11.48% 0.29%
PCRX Pacira BioSciences, Inc. Buy 12.12% 6.5%
CARA Cara Therapeutics, Inc. Sell -3.73% 2.55%
The percentage of cash held in the portfolio is: 68.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -13.23%
Assets Rebalanced
None
2024-12-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 12.04% 6.16%
MGNX MacroGenics, Inc. Buy 11.15% -1.76%
ESPR Esperion Therapeutics, Inc. Buy 11.09% -1.94%
PCRX Pacira BioSciences, Inc. Buy 11.68% 3.51%
CARA Cara Therapeutics, Inc. Sell -3.78% 0.36%
The percentage of cash held in the portfolio is: 57.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Buy All -10.49%
KIDS Buy All 10.65%
ENTA Buy All 21.95%
Assets Rebalanced
None
2024-12-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 11.8% 7.32%
MGNX MacroGenics, Inc. Buy 11.25% 2.35%
ESPR Esperion Therapeutics, Inc. Buy 13.54% 23.55%
PCRX Pacira BioSciences, Inc. Buy 10.93% 0%
TNDM Tandem Diabetes Care, Inc. Sell -7.45% -4.9%
KIDS OrthoPediatrics Corp. Sell -6.2% 12.71%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.73% 19.24%
CARA Cara Therapeutics, Inc. Sell -3.92% -6.57%
The percentage of cash held in the portfolio is: 75.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ITGR Sell All 1.13%
RVNC Sell All -27.34%
Assets Rebalanced
None
2024-12-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 28.99% 1.92%
APLS Apellis Pharmaceuticals, Inc. Buy 11.07% 2.64%
MGNX MacroGenics, Inc. Buy 11.1% 2.94%
ESPR Esperion Therapeutics, Inc. Buy 12.07% 12.26%
RVNC Revance Therapeutics, Inc. Buy 9.83% -8.39%
PCRX Pacira BioSciences, Inc. Buy 10.83% 0.94%
TNDM Tandem Diabetes Care, Inc. Sell -6.85% 1.6%
KIDS OrthoPediatrics Corp. Sell -6.27% 9.91%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.03% 27.73%
CARA Cara Therapeutics, Inc. Sell -3.5% 2.92%
The percentage of cash held in the portfolio is: 37.77%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMPH Buy All 4.97%
Assets Rebalanced
None
2024-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 29.08% 2.73%
APLS Apellis Pharmaceuticals, Inc. Buy 11.23% 4.6%
MGNX MacroGenics, Inc. Buy 11.02% 2.65%
ESPR Esperion Therapeutics, Inc. Buy 12.63% 18.06%
RVNC Revance Therapeutics, Inc. Buy 10.67% 0%
PCRX Pacira BioSciences, Inc. Buy 10.67% 0%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.19% 3.88%
TNDM Tandem Diabetes Care, Inc. Sell -7.31% -5.49%
KIDS OrthoPediatrics Corp. Sell -6.57% 5.17%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.34% 22.94%
CARA Cara Therapeutics, Inc. Sell -3.59% 0%
The percentage of cash held in the portfolio is: 44.7%
New Assets Added
  • CARA
  • RVNC
  • PCRX
Assets Removed
Asset Action Perf %
CUTR Buy All 23.21%
ARWR Sell All -11.63%
Assets Rebalanced
None
2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 28.93% 1.47%
APLS Apellis Pharmaceuticals, Inc. Buy 11.74% 8.55%
MGNX MacroGenics, Inc. Buy 11.74% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.96% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 10.77% 0%
CUTR Cutera, Inc. Sell -3.15% 21.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.5% 0.46%
TNDM Tandem Diabetes Care, Inc. Sell -7.42% -6.24%
KIDS OrthoPediatrics Corp. Sell -7.04% -0.82%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.4% 22.58%
The percentage of cash held in the portfolio is: 56.37%
New Assets Added
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 29.14% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 11.23% 4.63%
MGNX MacroGenics, Inc. Buy 11.49% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.8% 0%
FATE Fate Therapeutics, Inc. Buy 10.8% 0%
CUTR Cutera, Inc. Sell -3.27% 17.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.34% 1.91%
TNDM Tandem Diabetes Care, Inc. Sell -7.07% -2.03%
KIDS OrthoPediatrics Corp. Sell -6.84% 1.28%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.53% 20.23%
The percentage of cash held in the portfolio is: 56.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 11.34% -1.39%
ITGR Integer Holdings Corporation Buy 29.14% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 11.23% 4.63%
MGNX MacroGenics, Inc. Buy 11.49% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.8% 0%
FATE Fate Therapeutics, Inc. Buy 10.8% 0%
CUTR Cutera, Inc. Sell -3.27% 17.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.34% 1.91%
TNDM Tandem Diabetes Care, Inc. Sell -7.07% -2.03%
KIDS OrthoPediatrics Corp. Sell -6.84% 1.28%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.53% 20.23%
The percentage of cash held in the portfolio is: 45.24%
New Assets Added
  • ARWR
  • FATE
Assets Removed
Asset Action Perf %
HCSG Sell All 13.06%
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 11.05% 10.78%
NEOG Neogen Corporation Buy 11.47% -1.19%
ITGR Integer Holdings Corporation Buy 28.99% 1.48%
APLS Apellis Pharmaceuticals, Inc. Buy 10.83% 0%
MGNX MacroGenics, Inc. Buy 10.83% 0%
CUTR Cutera, Inc. Sell -2.8% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.24% 4.06%
TNDM Tandem Diabetes Care, Inc. Sell -6.87% 1.83%
KIDS OrthoPediatrics Corp. Sell -7.05% -0.74%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.41% 22.67%
The percentage of cash held in the portfolio is: 56.17%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 10.69% 6.67%
NEOG Neogen Corporation Buy 12.17% 4.46%
ITGR Integer Holdings Corporation Buy 28.96% 0.99%
CUTR Cutera, Inc. Sell -2.3% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.48% 1.37%
TNDM Tandem Diabetes Care, Inc. Sell -7.07% -0.69%
KIDS OrthoPediatrics Corp. Sell -7.19% -2.41%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.92% 15.63%
The percentage of cash held in the portfolio is: 78.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 18.73%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 12.02% 17.66%
HCSG Healthcare Services Group, Inc. Buy 10.36% 3.74%
NEOG Neogen Corporation Buy 12.22% 5.23%
ITGR Integer Holdings Corporation Buy 27.9% -2.37%
CUTR Cutera, Inc. Sell -2.15% 46.43%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.15% 5.36%
TNDM Tandem Diabetes Care, Inc. Sell -6.37% 8.92%
KIDS OrthoPediatrics Corp. Sell -6.62% 5.44%
ENTA Enanta Pharmaceuticals, Inc. Sell -5.95% 14.91%
The percentage of cash held in the portfolio is: 65.74%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 11.94% 17.18%
HCSG Healthcare Services Group, Inc. Buy 10.49% 5.39%
NEOG Neogen Corporation Buy 11.79% 1.81%
MGNX MacroGenics, Inc. Buy 9.2% -7.75%
ITGR Integer Holdings Corporation Buy 27.75% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.96% -5.24%
CUTR Cutera, Inc. Sell -2.29% 42.86%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.29% 3.21%
TNDM Tandem Diabetes Care, Inc. Sell -6.23% 10.65%
KIDS OrthoPediatrics Corp. Sell -6.22% 10.85%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.01% 13.91%
The percentage of cash held in the portfolio is: 42.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
VREX Sell All 13.22%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 10.67% 12.89%
CDMO Avid Bioservices, Inc. Buy 11.51% 15.15%
HCSG Healthcare Services Group, Inc. Buy 10.64% 8.95%
NEOG Neogen Corporation Buy 11.6% 2.09%
MGNX MacroGenics, Inc. Buy 9.63% -1.55%
ITGR Integer Holdings Corporation Buy 27.55% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.89% -3.91%
RGEN Repligen Corporation Buy 10.96% -5.34%
CUTR Cutera, Inc. Sell -2.31% 41.07%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.22% 2.23%
TNDM Tandem Diabetes Care, Inc. Sell -6.39% 6.57%
KIDS OrthoPediatrics Corp. Sell -6.04% 11.78%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.26% 8.49%
The percentage of cash held in the portfolio is: 21.79%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 26.23%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 10.56% 15.04%
NUTX Nutex Health Inc. Buy 12.35% 31.39%
CDMO Avid Bioservices, Inc. Buy 11.43% 17.76%
HCSG Healthcare Services Group, Inc. Buy 10.56% 11.32%
NEOG Neogen Corporation Buy 11.68% 5.86%
MGNX MacroGenics, Inc. Buy 9.26% -2.58%
ITGR Integer Holdings Corporation Buy 27.3% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.91% -0.89%
ALT Altimmune, Inc. Buy 8.22% 0.32%
RGEN Repligen Corporation Buy 11.25% 0%
CUTR Cutera, Inc. Sell -2.45% 35.71%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.08% 1.32%
TNDM Tandem Diabetes Care, Inc. Sell -6.44% 3.04%
KIDS OrthoPediatrics Corp. Sell -6.27% 5.68%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.26% 5.78%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
ARWR Sell All 11.73%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.91% 11.11%
VREX Varex Imaging Corporation Buy 10.63% 18.26%
NUTX Nutex Health Inc. Buy 13.93% 51.33%
CDMO Avid Bioservices, Inc. Buy 11.22% 18.05%
HCSG Healthcare Services Group, Inc. Buy 10.55% 13.61%
NEOG Neogen Corporation Buy 11.56% 6.97%
MGNX MacroGenics, Inc. Buy 9.86% 5.94%
ITGR Integer Holdings Corporation Buy 26.6% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.57% -1.24%
ALT Altimmune, Inc. Buy 8.02% 0%
CUTR Cutera, Inc. Sell -2.6% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.27% -3.51%
TNDM Tandem Diabetes Care, Inc. Sell -6.61% -1.63%
KIDS OrthoPediatrics Corp. Sell -6.08% 6.53%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.27% 3.7%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
IOVA Sell All -12.15%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.24% 13.48%
VREX Varex Imaging Corporation Buy 10.94% 20.74%
NUTX Nutex Health Inc. Buy 10.44% 12.45%
CDMO Avid Bioservices, Inc. Buy 11.34% 18.24%
IOVA Iovance Biotherapeutics, Inc. Buy 8.92% -3.45%
HCSG Healthcare Services Group, Inc. Buy 10.44% 11.51%
NEOG Neogen Corporation Buy 12.46% 14.37%
MGNX MacroGenics, Inc. Buy 10.65% 13.44%
ITGR Integer Holdings Corporation Buy 27.35% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 13.86% 0%
CUTR Cutera, Inc. Sell -2.62% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.47% -5.38%
TNDM Tandem Diabetes Care, Inc. Sell -6.73% -2.52%
KIDS OrthoPediatrics Corp. Sell -6.38% 2.88%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.45% 1.81%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
Asset Action Perf %
VCEL Sell All 34.9%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
VCEL Vericel Corporation Buy 13.31% 28.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.29% 13.07%
VREX Varex Imaging Corporation Buy 10.74% 17.52%
NUTX Nutex Health Inc. Buy 11.9% 27.16%
CDMO Avid Bioservices, Inc. Buy 11.44% 18.34%
IOVA Iovance Biotherapeutics, Inc. Buy 8.94% -3.99%
HCSG Healthcare Services Group, Inc. Buy 10.24% 8.4%
NEOG Neogen Corporation Buy 12.44% 13.18%
MGNX MacroGenics, Inc. Buy 10.64% 12.4%
ITGR Integer Holdings Corporation Buy 27.04% 0%
CUTR Cutera, Inc. Sell -2.65% 30.36%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.49% -4.82%
TNDM Tandem Diabetes Care, Inc. Sell -6.62% 0%
KIDS OrthoPediatrics Corp. Sell -6.62% 0%
ENTA Enanta Pharmaceuticals, Inc. Sell -6.62% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TNDM
  • KIDS
  • ENTA
  • ITGR
Assets Removed
Asset Action Perf %
EVH Buy All 42.39%
ARDX Sell All -16.06%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 12.46% 5.63%
VCEL Vericel Corporation Buy 12.47% 18.86%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.16% 10.49%
VREX Varex Imaging Corporation Buy 10.9% 17.93%
NUTX Nutex Health Inc. Buy 11.02% 16.4%
CDMO Avid Bioservices, Inc. Buy 11.55% 18.15%
IOVA Iovance Biotherapeutics, Inc. Buy 10.48% 11.33%
HCSG Healthcare Services Group, Inc. Buy 10.25% 7.31%
NEOG Neogen Corporation Buy 12.23% 10.04%
MGNX MacroGenics, Inc. Buy 11.03% 15.25%
EVH Evolent Health, Inc. Sell -4.82% -5.95%
CUTR Cutera, Inc. Sell -3.5% 8.93%
AMPH Amphastar Pharmaceuticals, Inc. Sell -7.23% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMPH
Assets Removed
None
Assets Rebalanced
Asset Action Weight
VCEL Buy 0.56%
NEOG Buy 0.89%
ARDX Buy 1.17%
ARWR Buy 1.45%
2024-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 10.71% 7.45%
VCEL Vericel Corporation Buy 10.71% 14.14%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 10.02% 10.23%
VREX Varex Imaging Corporation Buy 11.41% 19.42%
NUTX Nutex Health Inc. Buy 10.71% 9.47%
CDMO Avid Bioservices, Inc. Buy 10.71% 5.98%
HCSG Healthcare Services Group, Inc. Buy 10.71% 8.49%
IOVA Iovance Biotherapeutics, Inc. Buy 10.71% 10.06%
NEOG Neogen Corporation Buy 10.71% 8.93%
MGNX MacroGenics, Inc. Buy 10.71% 8.27%
EVH Evolent Health, Inc. Sell -5.03% -6.81%
CUTR Cutera, Inc. Sell -4.11% -3.57%
The percentage of cash held in the portfolio is: 2%
New Assets Added
None
Assets Removed
Asset Action Perf %
SMTI Buy All -11.47%
NVCR Buy All -19.24%
Assets Rebalanced
Asset Action Weight
ARWR Sell -1.57%
VCEL Sell -1.29%
NUTX Sell -2.27%
ARDX Sell -2.9%
CDMO Sell -2.98%
HCSG Sell -6.89%
IOVA Sell -7.14%
NEOG Buy 3.21%
MGNX Buy 5.79%
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 13.48% -2.48%
VCEL Vericel Corporation Buy 12.09% 5.42%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.88% 3.62%
VREX Varex Imaging Corporation Buy 11.41% 9.5%
NUTX Nutex Health Inc. Buy 12.01% -7.17%
CDMO Avid Bioservices, Inc. Buy 14.07% -0.19%
HCSG Healthcare Services Group, Inc. Buy 18.05% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 18.35% 3.72%
NEOG Neogen Corporation Buy 7.56% 0.63%
MGNX MacroGenics, Inc. Buy 4.75% -4.39%
EVH Evolent Health, Inc. Sell -5.17% -0.73%
SMTI Sanara MedTech Inc. Sell -7.8% -6.02%
NVCR NovoCure Limited Sell -8.37% -9.29%
CUTR Cutera, Inc. Sell -4.33% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CUTR
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ARDX Buy 1.18%
VREX Buy 2.03%
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 11.62% 0.83%
VCEL Vericel Corporation Buy 12.04% 4.51%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.6% 0.67%
VREX Varex Imaging Corporation Buy 9.39% 9.09%
NUTX Nutex Health Inc. Buy 11.84% -8.94%
CDMO Avid Bioservices, Inc. Buy 14.04% -0.87%
HCSG Healthcare Services Group, Inc. Buy 18.1% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 18.04% 1.45%
NEOG Neogen Corporation Buy 7.6% 0.7%
MGNX MacroGenics, Inc. Buy 4.99% 0%
EVH Evolent Health, Inc. Sell -5.22% -1.16%
SMTI Sanara MedTech Inc. Sell -7.85% -6.21%
NVCR NovoCure Limited Sell -8.2% -6.59%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
CUTR Buy All 21.33%
FATE Buy All 24.3%
IRWD Sell All -1.64%
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.27% -7.28%
ARDX Ardelyx, Inc. Buy 11.52% -2.81%
VCEL Vericel Corporation Buy 12.4% 4.63%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.77% -0.67%
VREX Varex Imaging Corporation Buy 9.6% 8.51%
NUTX Nutex Health Inc. Buy 12.01% -10.19%
CDMO Avid Bioservices, Inc. Buy 14% -3.86%
HCSG Healthcare Services Group, Inc. Buy 18.31% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 17.3% -5.35%
NEOG Neogen Corporation Buy 7.73% -0.42%
CUTR Cutera, Inc. Sell -4.51% 22.67%
FATE Fate Therapeutics, Inc. Sell -4.3% 26.17%
EVH Evolent Health, Inc. Sell -5.34% -0.69%
SMTI Sanara MedTech Inc. Sell -7.95% -4.6%
NVCR NovoCure Limited Sell -7.91% 0%
The percentage of cash held in the portfolio is: 2.1%
New Assets Added
  • NVCR
Assets Removed
Asset Action Perf %
ORMP Buy All 0.42%
Assets Rebalanced
Asset Action Weight
CDMO Buy 0.85%
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.96% -0.23%
ARDX Ardelyx, Inc. Buy 11.52% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 11.95% 3.2%
VCEL Vericel Corporation Buy 12.61% 8.89%
VREX Varex Imaging Corporation Buy 9.51% 10%
NUTX Nutex Health Inc. Buy 11.63% -10.96%
CDMO Avid Bioservices, Inc. Buy 11.94% -1.74%
HCSG Healthcare Services Group, Inc. Buy 17.98% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 17.51% -1.99%
NEOG Neogen Corporation Buy 7.59% 0%
CUTR Cutera, Inc. Sell -5.09% 10.67%
FATE Fate Therapeutics, Inc. Sell -4.83% 15.26%
ORMP Oramed Pharmaceuticals Inc. Sell -5.46% 4.18%
EVH Evolent Health, Inc. Sell -5.2% -0.34%
SMTI Sanara MedTech Inc. Sell -7.63% -2.69%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.55% -2.58%
ARDX Ardelyx, Inc. Buy 11.25% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12% 4.24%
VCEL Vericel Corporation Buy 12.49% 8.48%
VREX Varex Imaging Corporation Buy 9.34% 8.68%
NKTR Nektar Therapeutics Buy 8.06% -6.21%
NUTX Nutex Health Inc. Buy 12.56% -3.3%
CDMO Avid Bioservices, Inc. Buy 11.77% -2.51%
HCSG Healthcare Services Group, Inc. Buy 17.76% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 17.76% 0%
CUTR Cutera, Inc. Sell -5.06% 10.67%
FATE Fate Therapeutics, Inc. Sell -5.06% 10.59%
ORMP Oramed Pharmaceuticals Inc. Sell -5.5% 2.93%
EVH Evolent Health, Inc. Sell -5.24% -1.81%
SMTI Sanara MedTech Inc. Sell -7.69% -4.15%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.98% -7.04%
ARDX Ardelyx, Inc. Buy 11.9% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.93% 3.82%
VCEL Vericel Corporation Buy 12.94% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 19.24% 54.64%
VREX Varex Imaging Corporation Buy 9.92% 6.69%
NKTR Nektar Therapeutics Buy 8.47% -8.97%
NUTX Nutex Health Inc. Buy 13.75% -2.14%
CDMO Avid Bioservices, Inc. Buy 12.61% -3.47%
CUTR Cutera, Inc. Sell -5.23% 14.67%
FATE Fate Therapeutics, Inc. Sell -5.06% 17.45%
ORMP Oramed Pharmaceuticals Inc. Sell -6.07% 0.84%
EVH Evolent Health, Inc. Sell -5.77% -3.58%
SMTI Sanara MedTech Inc. Sell -8.02% -0.48%
The percentage of cash held in the portfolio is: 14.41%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 13.98% -6.57%
ORGO Organogenesis Holdings Inc. Buy 11.62% -6.82%
ARDX Ardelyx, Inc. Buy 12.01% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.74% 2.94%
VCEL Vericel Corporation Buy 12.61% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 19.01% 53.61%
VREX Varex Imaging Corporation Buy 9.8% 5.95%
NKTR Nektar Therapeutics Buy 8.61% -6.9%
NUTX Nutex Health Inc. Buy 13.83% -0.97%
CDMO Avid Bioservices, Inc. Buy 12.8% -1.45%
CUTR Cutera, Inc. Sell -5.28% 13.33%
FATE Fate Therapeutics, Inc. Sell -5.33% 12.46%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% 1.26%
EVH Evolent Health, Inc. Sell -5.44% 1.81%
SMTI Sanara MedTech Inc. Sell -7.94% 0%
The percentage of cash held in the portfolio is: 2.99%
New Assets Added
  • SMTI
Assets Removed
None
Assets Rebalanced
Asset Action Weight
NUTX Buy 1.12%
IRWD Buy 1.79%
CDMO Buy 1.83%
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.06% -6.57%
ORGO Organogenesis Holdings Inc. Buy 11.76% -6.17%
ARDX Ardelyx, Inc. Buy 11.49% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.8% 2.89%
VCEL Vericel Corporation Buy 12.49% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 19.74% 58.76%
VREX Varex Imaging Corporation Buy 9.79% 5.37%
NKTR Nektar Therapeutics Buy 9.03% -2.76%
NUTX Nutex Health Inc. Buy 11.28% -4.88%
CDMO Avid Bioservices, Inc. Buy 11.19% 0%
CUTR Cutera, Inc. Sell -5.38% 12%
FATE Fate Therapeutics, Inc. Sell -5.77% 5.61%
ORMP Oramed Pharmaceuticals Inc. Sell -6.09% 0.42%
EVH Evolent Health, Inc. Sell -5.38% 3.41%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.55% -4.23%
ORGO Organogenesis Holdings Inc. Buy 12.84% 0.65%
ARDX Ardelyx, Inc. Buy 12.12% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.33% 5.27%
VCEL Vericel Corporation Buy 12.58% -0.62%
CDXS Codexis, Inc. Buy 12.32% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 15.79% 24.74%
VREX Varex Imaging Corporation Buy 9.8% 3.64%
NKTR Nektar Therapeutics Buy 9.39% -0.69%
NUTX Nutex Health Inc. Buy 12.07% 0%
CUTR Cutera, Inc. Sell -5.8% 6.8%
FATE Fate Therapeutics, Inc. Sell -6.19% 0.62%
ORMP Oramed Pharmaceuticals Inc. Sell -6.18% 0.84%
EVH Evolent Health, Inc. Sell -5.61% 0.99%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
Assets Removed
Asset Action Perf %
IRTC Buy All -20.54%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.16% -1.64%
ORGO Organogenesis Holdings Inc. Buy 13.22% 0.97%
ARDX Ardelyx, Inc. Buy 12.65% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.75% 5.84%
VCEL Vericel Corporation Buy 12.71% -2.16%
CDXS Codexis, Inc. Buy 12.6% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 12.18% -6.19%
VREX Varex Imaging Corporation Buy 10.1% 4.13%
NKTR Nektar Therapeutics Buy 9.3% -4.14%
CUTR Cutera, Inc. Sell -5.96% 6.67%
FATE Fate Therapeutics, Inc. Sell -6.27% 1.87%
ORMP Oramed Pharmaceuticals Inc. Sell -6.28% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.67% 0.97%
EVH Evolent Health, Inc. Sell -5.81% 0%
The percentage of cash held in the portfolio is: 21.34%
New Assets Added
  • EVH
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.64% 4.23%
ORGO Organogenesis Holdings Inc. Buy 12.79% -0.32%
ARDX Ardelyx, Inc. Buy 12.3% -3.48%
BKD Brookdale Senior Living Inc. Buy 13.92% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.71% 7.64%
VCEL Vericel Corporation Buy 12.31% -3.37%
CDXS Codexis, Inc. Buy 12.66% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 12.34% -3.09%
VREX Varex Imaging Corporation Buy 9.51% 0%
NKTR Nektar Therapeutics Buy 9.51% 0%
CUTR Cutera, Inc. Sell -5.51% 12%
FATE Fate Therapeutics, Inc. Sell -6.28% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.29% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.6% 0.35%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.36% 3.05%
ORGO Organogenesis Holdings Inc. Buy 13.19% 3.9%
ARDX Ardelyx, Inc. Buy 12.46% -1.16%
BKD Brookdale Senior Living Inc. Buy 12.64% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.94% 2.69%
VCEL Vericel Corporation Buy 12.56% -0.33%
RDNT RadNet, Inc. Buy 12.63% 0.2%
CDXS Codexis, Inc. Buy 12.59% 0%
SGMO Sangamo Therapeutics, Inc. Buy 12.59% 0%
CUTR Cutera, Inc. Sell -5.7% 8%
FATE Fate Therapeutics, Inc. Sell -5.89% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -6.09% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.33% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -5.55% 0.18%
The percentage of cash held in the portfolio is: 14.59%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.21% 0.7%
ORGO Organogenesis Holdings Inc. Buy 12.87% 0.32%
ARDX Ardelyx, Inc. Buy 12.63% -0.83%
BKD Brookdale Senior Living Inc. Buy 12.73% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.73% 0%
VCEL Vericel Corporation Buy 12.73% 0%
RDNT RadNet, Inc. Buy 12.73% 0%
CUTR Cutera, Inc. Sell -5.93% 5.33%
FATE Fate Therapeutics, Inc. Sell -5.95% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -6.24% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.19% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -5.54% 1.35%
The percentage of cash held in the portfolio is: 40.2%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.2% 0%
ORGO Organogenesis Holdings Inc. Buy 12.87% -0.32%
ARDX Ardelyx, Inc. Buy 12.81% 0%
CUTR Cutera, Inc. Sell -6.39% -1.33%
FATE Fate Therapeutics, Inc. Sell -6.07% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -6.28% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.14% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -5.71% -1.12%
The percentage of cash held in the portfolio is: 91.7%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.01% -1.17%
ORGO Organogenesis Holdings Inc. Buy 12.61% -1.95%
CUTR Cutera, Inc. Sell -6.11% 2.67%
FATE Fate Therapeutics, Inc. Sell -5.75% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -6.3% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.15% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -5.4% 4.05%
The percentage of cash held in the portfolio is: 104.09%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.26% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.86% 0%
ORGO Organogenesis Holdings Inc. Buy 12.86% 0%
CUTR Cutera, Inc. Sell -6.28% 0%
FATE Fate Therapeutics, Inc. Sell -6.3% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.17% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.63% 0%
AXSM Axsome Therapeutics, Inc. Sell -5.63% 0%
The percentage of cash held in the portfolio is: 92.02%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
Asset Action Perf %
CERS Buy All 19.43%
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.17% 0%
CERS Cerus Corporation Sell -4.85% 19.91%
CUTR Cutera, Inc. Sell -6.29% 0%
FATE Fate Therapeutics, Inc. Sell -6.29% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -6.29% 0%
The percentage of cash held in the portfolio is: 111.54%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-10-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Sell -5% 17.54%
The percentage of cash held in the portfolio is: 105%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All -1.88%
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Sell -6.18% -1.88%
CERS Cerus Corporation Sell -5.03% 17.06%
The percentage of cash held in the portfolio is: 111.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Buy All 3.4%
PODD Sell All 13.51%
Assets Rebalanced
None
2024-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 23.45% 15.17%
AVXL Anavex Life Sciences Corp. Sell -5.93% 3.57%
VREX Varex Imaging Corporation Sell -6.1% -0.85%
CERS Cerus Corporation Sell -5.1% 15.64%
The percentage of cash held in the portfolio is: 93.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All -4.63%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 23.49% 16.82%
STAA STAAR Surgical Company Sell -6.2% 4.11%
AVXL Anavex Life Sciences Corp. Sell -5.63% 7.31%
VREX Varex Imaging Corporation Sell -5.93% 0.6%
CERS Cerus Corporation Sell -5.01% 16.11%
The percentage of cash held in the portfolio is: 99.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 8.57%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 13.29% 8%
PODD Insulet Corporation Buy 23.44% 16.92%
NVCR NovoCure Limited Buy 18.46% -8.98%
STAA STAAR Surgical Company Sell -6.43% 0.25%
AVXL Anavex Life Sciences Corp. Sell -5.73% 5.44%
VREX Varex Imaging Corporation Sell -5.64% 5.21%
CERS Cerus Corporation Sell -5.08% 14.69%
The percentage of cash held in the portfolio is: 67.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 13.36% 9.14%
PODD Insulet Corporation Buy 23.31% 16.9%
NVCR NovoCure Limited Buy 18.47% -8.42%
MYGN Myriad Genetics, Inc. Buy 9.28% -0.15%
STAA STAAR Surgical Company Sell -6.02% 6.21%
AVXL Anavex Life Sciences Corp. Sell -5.62% 6.63%
VREX Varex Imaging Corporation Sell -5.97% -0.77%
CERS Cerus Corporation Sell -4.99% 15.64%
The percentage of cash held in the portfolio is: 58.18%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 13.28% 10.29%
PODD Insulet Corporation Buy 22.7% 15.73%
ESPR Esperion Therapeutics, Inc. Buy 5.56% -8.2%
NVCR NovoCure Limited Buy 19.19% -3.32%
MYGN Myriad Genetics, Inc. Buy 9.37% 2.48%
STAA STAAR Surgical Company Sell -5.93% 6.12%
AVXL Anavex Life Sciences Corp. Sell -5.68% 4.08%
VREX Varex Imaging Corporation Sell -5.37% 7.78%
CERS Cerus Corporation Sell -4.97% 14.69%
The percentage of cash held in the portfolio is: 51.85%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 6.76%
Assets Rebalanced
None
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 11.86% 13.89%
AADI Aadi Bioscience, Inc. Buy 12.59% 5.14%
PODD Insulet Corporation Buy 22.49% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 5.86% -2.73%
NVCR NovoCure Limited Buy 19.71% -0.17%
MYGN Myriad Genetics, Inc. Buy 9.65% 6.04%
STAA STAAR Surgical Company Sell -6.24% 0.59%
AVXL Anavex Life Sciences Corp. Sell -5.47% 7.14%
VREX Varex Imaging Corporation Sell -5.5% 5.04%
CERS Cerus Corporation Sell -5.41% 6.64%
The percentage of cash held in the portfolio is: 40.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All -8.6%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 11.69% 11.15%
AADI Aadi Bioscience, Inc. Buy 12.99% 7.43%
PODD Insulet Corporation Buy 22.55% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 5.85% -3.83%
NVCR NovoCure Limited Buy 19.83% -0.5%
MYGN Myriad Genetics, Inc. Buy 9.5% 3.45%
CDMO Avid Bioservices, Inc. Sell -6.84% -6.71%
STAA STAAR Surgical Company Sell -6.15% 3.06%
AVXL Anavex Life Sciences Corp. Sell -5.77% 3.06%
VREX Varex Imaging Corporation Sell -5.77% 1.45%
CERS Cerus Corporation Sell -5.71% 2.37%
The percentage of cash held in the portfolio is: 47.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.62% -1.69%
AGEN Agenus Inc. Buy 10.79% -0.18%
AADI Aadi Bioscience, Inc. Buy 12.65% 1.71%
PODD Insulet Corporation Buy 22.45% 10.8%
TVTX Travere Therapeutics, Inc. Buy 8.37% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 5.92% -5.46%
NVCR NovoCure Limited Buy 19.19% -6.37%
MYGN Myriad Genetics, Inc. Buy 9.47% 0.26%
CDMO Avid Bioservices, Inc. Sell -6.54% 0.85%
STAA STAAR Surgical Company Sell -6.07% 6.89%
AVXL Anavex Life Sciences Corp. Sell -5.21% 14.88%
VREX Varex Imaging Corporation Sell -5.84% 2.99%
CERS Cerus Corporation Sell -5.85% 2.84%
The percentage of cash held in the portfolio is: 30.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.72% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.67% -9.62%
AGEN Agenus Inc. Buy 10.03% -6.22%
AADI Aadi Bioscience, Inc. Buy 12.73% 3.43%
PODD Insulet Corporation Buy 21.5% 7.2%
TVTX Travere Therapeutics, Inc. Buy 8.29% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 5.75% -7.1%
NVCR NovoCure Limited Buy 18.67% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.41% 0.63%
CDMO Avid Bioservices, Inc. Sell -5.52% 15.41%
STAA STAAR Surgical Company Sell -5.99% 7.17%
AVXL Anavex Life Sciences Corp. Sell -5.31% 12.41%
VREX Varex Imaging Corporation Sell -5.21% 12.56%
CERS Cerus Corporation Sell -5.7% 4.27%
The percentage of cash held in the portfolio is: 20.96%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 11.15% 3%
CARA Cara Therapeutics, Inc. Buy 10.17% -6.12%
AGEN Agenus Inc. Buy 9.8% -9.51%
AADI Aadi Bioscience, Inc. Buy 13.03% 4.57%
PODD Insulet Corporation Buy 21.32% 5.05%
TVTX Travere Therapeutics, Inc. Buy 7.17% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 5.65% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 19.93% -3.01%
NVCR NovoCure Limited Buy 19.2% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.46% 0%
CDMO Avid Bioservices, Inc. Sell -5.51% 16.54%
STAA STAAR Surgical Company Sell -6.28% 3.86%
AVXL Anavex Life Sciences Corp. Sell -5.37% 12.41%
VREX Varex Imaging Corporation Sell -5.95% 1.28%
CERS Cerus Corporation Sell -5.77% 4.27%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.59% -1.42%
ORGO Organogenesis Holdings Inc. Buy 10.03% -6.71%
CARA Cara Therapeutics, Inc. Buy 10.06% -6.41%
AGEN Agenus Inc. Buy 9.83% -8.59%
AADI Aadi Bioscience, Inc. Buy 12.72% 2.86%
PODD Insulet Corporation Buy 21.31% 5.72%
TVTX Travere Therapeutics, Inc. Buy 6.44% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 5.85% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 20.4% 0%
NVCR NovoCure Limited Buy 20.39% 0%
CDMO Avid Bioservices, Inc. Sell -5.58% 14.93%
STAA STAAR Surgical Company Sell -6.25% 3.61%
AVXL Anavex Life Sciences Corp. Sell -5.76% 5.44%
VREX Varex Imaging Corporation Sell -6.12% -2.31%
CERS Cerus Corporation Sell -5.9% 1.42%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.25% -5.21%
ORGO Organogenesis Holdings Inc. Buy 10.31% -4.59%
CARA Cara Therapeutics, Inc. Buy 10.15% -6.12%
AGEN Agenus Inc. Buy 9.59% -11.33%
AADI Aadi Bioscience, Inc. Buy 12.8% 2.86%
PODD Insulet Corporation Buy 21.08% 3.96%
TVTX Travere Therapeutics, Inc. Buy 6.55% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 6.23% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 20.52% 0%
CDMO Avid Bioservices, Inc. Sell -5.76% 12.67%
STAA STAAR Surgical Company Sell -6.35% 2.72%
AVXL Anavex Life Sciences Corp. Sell -5.85% 4.42%
VREX Varex Imaging Corporation Sell -6.02% 0%
CERS Cerus Corporation Sell -6.02% 0%
The percentage of cash held in the portfolio is: 22.52%
New Assets Added
  • VREX
  • CERS
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.53% -2.65%
ORGO Organogenesis Holdings Inc. Buy 10.44% -3.53%
CARA Cara Therapeutics, Inc. Buy 10.45% -3.5%
AGEN Agenus Inc. Buy 9.8% -9.51%
CERS Cerus Corporation Buy 11.46% -7.98%
AADI Aadi Bioscience, Inc. Buy 12.38% -0.57%
PODD Insulet Corporation Buy 20.52% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 18.18% -10.38%
TVTX Travere Therapeutics, Inc. Buy 6.27% 0%
ESPR Esperion Therapeutics, Inc. Buy 6.27% 0%
CDMO Avid Bioservices, Inc. Sell -6.07% 8.03%
STAA STAAR Surgical Company Sell -6.52% 0.15%
AVXL Anavex Life Sciences Corp. Sell -5.69% 7.14%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
PINC Buy All -4.4%
VERU Buy All -12.35%
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.91% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.83% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.63% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.66% 3.79%
AGEN Agenus Inc. Buy 9.59% -6.58%
CERS Cerus Corporation Buy 11.12% -5.88%
AADI Aadi Bioscience, Inc. Buy 11.34% -4%
NEOG Neogen Corporation Buy 16.41% -2.15%
PODD Insulet Corporation Buy 19.25% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 19.25% 0%
CDMO Avid Bioservices, Inc. Sell -6.05% 3.4%
STAA STAAR Surgical Company Sell -6.11% 1.42%
PINC Premier, Inc. Sell -6.21% -0.3%
AVXL Anavex Life Sciences Corp. Sell -5.81% 0%
VERU Veru Inc. Sell -5.81% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AVXL
  • VERU
  • PODD
  • EGRX
Assets Removed
Asset Action Perf %
EGRX Buy All -9.7%
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.75% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.92% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.37% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.46% 4.66%
AGEN Agenus Inc. Buy 10.28% 2.93%
CERS Cerus Corporation Buy 11.2% -2.52%
AADI Aadi Bioscience, Inc. Buy 11.03% -4%
NEOG Neogen Corporation Buy 16.32% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -6% -0.42%
CDMO Avid Bioservices, Inc. Sell -5.93% 2.74%
STAA STAAR Surgical Company Sell -6.03% 0%
PINC Premier, Inc. Sell -6.03% 0%
The percentage of cash held in the portfolio is: 34.64%
New Assets Added
  • STAA
  • PINC
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.75% 6.09%
ARDX Ardelyx, Inc. Buy 9.67% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.76% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.46% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.54% 7.87%
AGEN Agenus Inc. Buy 10.49% 7.31%
CERS Cerus Corporation Buy 11.24% 0%
AADI Aadi Bioscience, Inc. Buy 11.24% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.79% 0.84%
CDMO Avid Bioservices, Inc. Sell -5.84% 2.08%
The percentage of cash held in the portfolio is: 24.48%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.12% -0.59%
ARDX Ardelyx, Inc. Buy 9.91% -0.31%
APLS Apellis Pharmaceuticals, Inc. Buy 10.01% 0.64%
ORGO Organogenesis Holdings Inc. Buy 10.3% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.09% 1.46%
AGEN Agenus Inc. Buy 10.55% 6.03%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.72% 3.8%
CDMO Avid Bioservices, Inc. Sell -6.07% 0%
The percentage of cash held in the portfolio is: 47.82%
New Assets Added
  • CDMO
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.94% -4.32%
ARDX Ardelyx, Inc. Buy 9.68% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 10.01% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.9% -2.83%
CARA Cara Therapeutics, Inc. Buy 10.2% 0%
AGEN Agenus Inc. Buy 10.2% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.71% 6.33%
The percentage of cash held in the portfolio is: 42.79%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 12.95% -2.95%
ARDX Ardelyx, Inc. Buy 10.06% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 10.06% 0%
ORGO Organogenesis Holdings Inc. Buy 10.06% 0%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.47% 9.07%
The percentage of cash held in the portfolio is: 62.35%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 13.15% -1.57%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.75% 4.43%
The percentage of cash held in the portfolio is: 92.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Buy All 0.74%
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 12.24% 7.37%
CYH Community Health Systems, Inc. Buy 12.64% -4.91%
PODD Insulet Corporation Sell -5.81% 6.55%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.17% 13.71%
The percentage of cash held in the portfolio is: 86.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.47% -3.03%
RCM R1 RCM Inc. Buy 12.54% 7.14%
CYH Community Health Systems, Inc. Buy 12.6% -7.66%
PODD Insulet Corporation Sell -6.24% 2.34%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.52% 10.34%
The percentage of cash held in the portfolio is: 76.14%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 10.64% -0.76%
RCM R1 RCM Inc. Buy 12.44% 7.06%
CYH Community Health Systems, Inc. Buy 12.83% -5.3%
RMD ResMed Inc. Buy 14.78% 3.67%
PODD Insulet Corporation Sell -6.2% 2.25%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.62% 8.02%
The percentage of cash held in the portfolio is: 61.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.56% -8.52%
OPK OPKO Health, Inc. Buy 10.84% 2.27%
RCM R1 RCM Inc. Buy 12.39% 7.83%
CYH Community Health Systems, Inc. Buy 13.14% -1.96%
RMD ResMed Inc. Buy 15.15% 7.5%
PODD Insulet Corporation Sell -6.32% -0.76%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.86% 2.95%
The percentage of cash held in the portfolio is: 51.1%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.52% -8.24%
OPK OPKO Health, Inc. Buy 11.01% 4.55%
RCM R1 RCM Inc. Buy 12.38% 8.44%
CYH Community Health Systems, Inc. Buy 13.1% -1.57%
HQY HealthEquity, Inc. Buy 12.8% -3.84%
HCSG Healthcare Services Group, Inc. Buy 2.9% -3.72%
RMD ResMed Inc. Buy 14.44% 3.13%
PODD Insulet Corporation Sell -6.3% -1.17%
EGRX Eagle Pharmaceuticals, Inc. Sell -6.05% -0.84%
The percentage of cash held in the portfolio is: 36.2%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.32% 1.14%
OPK OPKO Health, Inc. Buy 11.13% 7.58%
RCM R1 RCM Inc. Buy 11.09% -1.15%
FATE Fate Therapeutics, Inc. Buy 8.92% -4.31%
CYH Community Health Systems, Inc. Buy 13.52% 3.34%
HQY HealthEquity, Inc. Buy 12.68% -3.09%
HCSG Healthcare Services Group, Inc. Buy 2.92% -1.12%
RMD ResMed Inc. Buy 14.11% 2.5%
PODD Insulet Corporation Sell -6.1% 0.31%
EGRX Eagle Pharmaceuticals, Inc. Sell -6% -1.69%
The percentage of cash held in the portfolio is: 27.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 27.55%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.7% 26.42%
PDSB PDS Biotechnology Corporation Buy 10.14% -1.7%
OPK OPKO Health, Inc. Buy 11.34% 8.33%
RCM R1 RCM Inc. Buy 11.23% -1%
FATE Fate Therapeutics, Inc. Buy 8.68% -7.9%
CYH Community Health Systems, Inc. Buy 13.41% 1.38%
HQY HealthEquity, Inc. Buy 12.81% -3.16%
HCSG Healthcare Services Group, Inc. Buy 2.98% -0.43%
RMD ResMed Inc. Buy 13.91% 0%
PODD Insulet Corporation Sell -6.15% 0.6%
EGRX Eagle Pharmaceuticals, Inc. Sell -5.96% 0%
The percentage of cash held in the portfolio is: 15.91%
New Assets Added
  • EGRX
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.72% 30.89%
PDSB PDS Biotechnology Corporation Buy 10.82% 8.52%
OPK OPKO Health, Inc. Buy 10.96% 8.33%
RCM R1 RCM Inc. Buy 10.69% -2.61%
FATE Fate Therapeutics, Inc. Buy 8.85% -2.87%
CLDX Celldex Therapeutics, Inc. Buy 10.27% -4.26%
SMTI Sanara MedTech Inc. Buy 12.09% -5.45%
CYH Community Health Systems, Inc. Buy 13.02% 1.77%
HQY HealthEquity, Inc. Buy 12.57% -1.69%
HCSG Healthcare Services Group, Inc. Buy 2.89% 0%
PODD Insulet Corporation Sell -5.89% 1.61%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
RMD Buy All -5.84%
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 11.02% 26.12%
PDSB PDS Biotechnology Corporation Buy 10.73% 10.23%
OPK OPKO Health, Inc. Buy 11.08% 12.12%
RCM R1 RCM Inc. Buy 10.69% -0.19%
FATE Fate Therapeutics, Inc. Buy 8.69% -2.33%
PTGX Protagonist Therapeutics, Inc. Buy 9.53% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 10.64% 1.6%
SMTI Sanara MedTech Inc. Buy 12.49% 0%
CYH Community Health Systems, Inc. Buy 12.49% 0%
HQY HealthEquity, Inc. Buy 12.49% 0%
PODD Insulet Corporation Sell -5.79% 0.85%
RMD ResMed Inc. Sell -6.05% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RMD
  • SMTI
  • CYH
  • HQY
Assets Removed
None
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings